Target intelligence / Profile preview

Langerin (CD207)

Target
CD207
Molecular classification
Receptor (type II transmembrane protein), C-type lectin, Pattern recognition receptor (PRR), Mannose-binding lectin
01

Overview

Langerin (CD207) is a type II transmembrane protein expressed primarily on Langerhans cells—a dendritic cell subset found in the skin and mucosal tissues. It is part of the C-type lectin receptor family and features a carbohydrate recognition domain that binds high mannose oligosaccharides and other glycans, facilitating the pathogen recognition and uptake necessary for antigen processing and presentation. Langerin’s ability to internalize antigens drives the formation of Birbeck granules, specialized organelles unique to Langerhans cells. Functionally, it acts both as an innate antiviral receptor (notably protecting against HIV-1 by capturing and degrading the virus) and as a mediator of adaptive immunity, presenting processed antigens to T cells. Besides defending against pathogens, Langerin expression is implicated in immune tolerance, tumor immunity, and the regulation of skin inflammation. Gene polymorphisms affecting the ligand binding of Langerin may influence infectious disease susceptibility and immune function. If additional specification is needed (e.g., species or isoform), refer to "CD207" in humans.

Other names
CD207C-type lectin domain family 4 member KLangerhans cell-specific antigenLangerhans cell antigen
02

Mechanism of action

Antigen delivery and presentation (candidate vaccines or experimental conjugates targeting Langerin to enhance adaptive immunity); Pathogen uptake/clearance through receptor-mediated endocytosis

03

Biological functions

Antigen uptake and internalizationPathogen recognition and binding (especially high mannose carbohydrates)Antiviral defense (notably against HIV-1)Antigen presentation to T cellsPromotion of immune responses, including tumor immunityImmune tolerance in skin
04

Disease associations

Infection (HIV-1, Candida albicans, Mycobacterium leprae)Cancer (expression alters tumor immunity)Inflammation (inflammatory skin conditions, regulation of skin immune homeostasis)
05

Safety considerations

Potential depletion or modulation of Langerhans cells, which may impair skin immune surveillance or toleranceOveractivation may provoke excessive immune response or inflammationEffects of gene polymorphisms can impact susceptibility to infection
06

Interacting drugs

No clinically approved drugs are currently known to directly target Langerin. However, research into targeting Langerin for vaccine delivery or immune modulation is ongoing, and various experimental antigen conjugates are under investigation
07

Biomarkers

Langerin (CD207) expression is a clinical/immunohistochemical marker to identify and quantify Langerhans cells, especially in cancer, inflammatory skin disease, and immune cell profiling

Beyond the preview

Go deeper on Langerin (CD207).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Langerin (CD207).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call